Occudo Quantitative Strategies LP Intellia Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$53.92 - $71.7 $2.4 Million - $3.19 Million
-44,447 Reduced 70.49%
18,610 $1.04 Million
Q2 2022

Aug 15, 2022
BUY
$38.49 - $76.21 $1.3 Million - $2.57 Million
33,682 Added 114.66%
63,057 $3.26 Million
Q1 2022

May 16, 2022
BUY
$58.27 - $118.99 $1.71 Million - $3.5 Million
29,375 New
29,375 $2.14 Million
Q1 2021

May 14, 2021
SELL
$46.59 - $83.68 $339,687 - $610,110
-7,291 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$18.83 - $63.53 $137,289 - $463,197
7,291 New
7,291 $397,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email